Since the first case-control study of the relation of sexual characteristics and prostate cancer was reported by Steele et al in 19711 other studies have confirmed the findings. Krain confirmed the greater number of sexual partners and higher coital frequency experienced by cancer of the prostate patients compared with their controls. Both Krain2 and Jackson et al3 found a higher proportion of cases than controls with histories of venereal disease.
It was deduced that sexual activity was a reflection of hormonal activity and the increased frequency of venereal disease a consequence of greater sexual drive among the cases. Armerian et al4 assumed an underlying genetic susceptibility among cases in hypothesising a hormonal model for prostatic cancer, the genetic factor predisposing to higher fertility and prostatic cancer. That hypothesis would also explain the familial history of the disease which has been recorded by Woolf, 5 
Method
The objectives of the present study were to identify any association between cancer of the prostate and (a) a past history of venereal infection or (b) previous treatment with parenteral arsenical drugs. A case-control design was used for the study.
All patients treated for prostatic cancer at the National Defence Medical Center (NDMC) between 1962 and 1982 were identified from the hospital records. Each was matched by age at the time of treatment with two control subjects, one who had been treated at NDMC for benign prostatic hypertrophy (group 1) and another who had been treated for medical or surgical non-cancerous conditions (group 2). These control groups were similar to those used by the authors in the 1971 study. Cancer cases were accepted only after corroboration of the histological diagnosis. The age at diagnosis, blood group, height, weight, blood pressure, marital status, smoking history, and alcohol consumption were noted.
Permission was obtained to review the records of the NDMC in Ottawa, giving adequate safeguards to the maintenance of confidentiality. The military service records of past members of the armed forces are stored in the National Archives, and permission to examine these was also obtained. Thus documented information on part of the past medical history of the selected study subjects was available, for example, age at enlistment, whether career or war-time service, job category, entry and discharge ranks, diagnoses and dates of venereal infections, treatment received for venereal infection, and age at time of infection. No patient was interviewed; no information was obtained from individual recall, and all of the data abstracted had been recorded objectively by a third party.
The data were coded and entered into an IBM computer. Analyses were made using the Statistical Analysis System (SAS) program.
Results
A total of 83 cases of prostatic cancer met the entry criteria. The mean age of the cases was 69-9 years (SD 10-0), median 71 0 years, and matching with two controls was possible to within 1 year of age. There was a significant difference for past history of syphilis between cases and the combined control groups, X' = 6-44, p<005.
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NS
The case and control groups were examined for a possible cohort effect and none was found. The subjects had been closely age matched but there was no obvious difference in occupation, rank or theatre of operations.
Discussion
Military medical records may not be complete, particularly in peace time when there may be more likelihood of men attending civilian doctors. However, we have no reason to believe that there were differences in rank or location of service between the cases and control groups which would result in more inaccuracy in one group than in the others. It is likely that the accuracy or completeness of military records is greater than that of individual patient recall or past history as recorded on hospital patient records. It must also be remembered that the documentation of illness and treatment covered only the period of the men's service in the armed forces.
This study did not demonstrate, as others have, a difference in the incidence of undifferentiated venereal diseases between the cases of prostatic cancer and their controls. It did show that, while there were no differences between the groups for all venereal disease or gonorrhoea, there was a significant difference at the p<005 level in the incidence of syphilis when the data were analysed with the control groups combined. When analysis was made with the control groups separated the difference between cases and control group 1 (benign prostatic hypertrophy cases) remained at the p<0 05 level; with control group 2 the difference was just short of significance at the p = 0-05 level. One must consider the real meaning of chance at 1 in 19 as 230 opposed to 1 in 20, the latter being a somewhat arbitrary cut point of significance.
Matched pair analysis provided a similar result for control group 1, with an odds ratio of 5-5 for cases, but although the significance of difference dropped in the second control group the odds ratio was 2-75.
Matched data analysis using both control groups showed a difference between cases and controls which was again just short of the p<005 level, but the odds ratio was 3 66.
From the relative risk estimates and the closeness of all significances of difference to 0<0 05, one must deduce that the association between acquired syphilis and cancer of the prostate is probably real.
The possibility of an association with syphilis was strengthened by the observation that cases with a past history of syphilis had the diagnosis of prostatic cancer made at an earlier age than those with a history of gonorrhoea or those without a history of venereal disease of any type. This difference in age was statistically significant for syphilis but not for gonorrhoea.
Men who had had gonorrhoea acquired the infection at a younger mean age than those who had syphilis. The mean latent period between syphilis infection and the onset of cancer of the prostate was shorter than the mean latent period for gonorrhoea victims-33-7 years versus 406 years.
These age and latency period differences suggest exposure to a more active carcinogenic stimulus or to a higher dose of the carcinogen. The carcinogen does not appear to be related to earlier sexual intercourse or coitus with multiple partners per se but rather to the acquisition of a specific infection or some other factor associated with that infection. We could not find evidence that that other factor was treatment with arsenical drugs.
There have been several suggestions, as the result of previous studies, that the higher frequency of venereal disease history among prostatic cancer victims reflects a more intense sexual drive and thus supports the hypothesis that male hormones are somehow carcinogenic for the prostate. While this study does not refute that hypothesis or gainsay the previously found associations between the disease and sexual drive, it does suggest that syphilis had a more specific association with the subsequent development of prostatic cancer than does venereal disease in general. Syphilitic glossitis leads to the development of leukoplakia, which frequently R E M Lees, R Steele, and D Wardle becomes malignant."2 The Treponema pallidum might in certain circumstances be carcinogenic for the prostate. There was not evidence that the gonococcus had a similar role.
Syphilis is obviously not a necessary precursor of prostatic cancer, but a past history of syphilis having an odds ratio of 2-75 to 5 5 in separate control groups, further investigation of the nature of the association is warranted.
